Clinical validity of endoscopic submucosal dissection for submucosal invasive gastric cancer: a single-center study. (scientific article published on 23 July 2011)

Lymph node metastasis from intestinal-type early gastric cancer: experience in a single institution and reassessment of the extended criteria for endoscopic submucosal dissection

Q37765730

Expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in early gastric carcinoma: correlation with clinicopathological parameters

Q38442031

Usefulness of endoscopic ultrasonography in determining the depth of invasion and indication for endoscopic treatment of early gastric cancer

Q42446484

Endoscopic submucosal dissection in gastric neoplasia - experience from a European center

Q44609349

Advantage of endoscopic submucosal dissection compared with EMR for early gastric cancer.

Q51098758

Japanese gastric cancer treatment guidelines 2010 (ver. 3).

Q51568719

Therapeutic outcomes in 1000 cases of endoscopic submucosal dissection for early gastric neoplasms: Korean ESD Study Group multicenter study.

Q51841904

Histologic grade and cellular proliferation at the deepest invasive portion correlate with the high malignancy of submucosal invasive gastric carcinoma

Q72303284

A new technique for endoscopic mucosal resection with an insulated-tip electrosurgical knife improves the completeness of resection of intramucosal gastric neoplasms

Q77847731

Endoscopic submucosal dissection for early gastric cancer: results and degrees of technical difficulty as well as success

Q79291039

Endoscopic submucosal dissection for residual/local recurrence of early gastric cancer after endoscopic mucosal resection

Q79291042

Lymph node status in patients with submucosal gastric cancer

Q80224894

Factors related to lymph node metastasis and the feasibility of endoscopic mucosal resection for treating poorly differentiated adenocarcinoma of the stomach

Q80526941

Characteristics of submucosal gastric carcinoma with lymph node metastatic disease

Q81366814

Endoscopic submucosal dissection for early gastric cancer: a large-scale feasibility study

Q82565561

Endoscopic submucosal dissection for submucosal invasive gastric cancer and curability criteria

Q83098816

Outcomes of endoscopic submucosal dissection for early gastric cancer with special reference to validation for curability criteria

Q83342803

Endoscopic resection of early gastric cancer treated by guideline and expanded National Cancer Centre criteria

Q83367528

Clinical impact of a strategy involving endoscopic submucosal dissection for early gastric cancer: determining the optimal pathway

Q83426491

Mixed-histologic-type submucosal invasive gastric cancer as a risk factor for lymph node metastasis: feasibility of endoscopic submucosal dissection

Q83775716

Japanese classification of gastric carcinoma: 3rd English edition

Q84106763

Predicting the absence of lymph node metastasis of submucosal invasive gastric cancer: expansion of the criteria for curative endoscopic resection

Q84581166

A second-look endoscopy after endoscopic submucosal dissection for gastric epithelial neoplasm may be unnecessary: a retrospective analysis of postendoscopic submucosal dissection bleeding

Q84923468

Risk factors for bleeding after endoscopic submucosal dissection of gastric epithelial neoplasm

Q84996394

P433

issue

P304

page(s)

97-105

P577

publication date

2011-07-23

P1433

published in

Gastric Cancer

Q15724608

P1476

title

Clinical validity of endoscopic submucosal dissection for submucosal invasive gastric cancer: a single-center study.

P478

volume

Reverse relations

cites work (P2860)

Q37617030	Characteristics of metachronous gastric tumors after endoscopic submucosal dissection for gastric intraepithelial neoplasms.
Q93058762	Clinical Usefulness of Dual Red Imaging in Gastric Endoscopic Submucosal Dissection: A Pilot Study
Q86505609	Clinical validity of the expanded criteria for endoscopic resection of undifferentiated-type early gastric cancer based on long-term outcomes
Q33810633	Continued use of low-dose aspirin does not increase the risk of bleeding during or after endoscopic submucosal dissection for early gastric cancer
Q33695279	Endoscopic submucosal dissection for early gastric cancer in cases preoperatively contraindicated for endoscopic treatment
Q42465120	International comparison of the German evidence-based S3-guidelines on the diagnosis and multimodal treatment of early and locally advanced gastric cancer, including adenocarcinoma of the lower esophagus
Q38154263	Long-term outcome of extended endoscopic submucosal dissection for early gastric cancer with differentiated histology
Q40927044	Long-term prognosis after endoscopic submucosal dissection for early gastric cancer in super-elderly patients
Q34366842	Minimally invasive surgery in gastric cancer
Q53256238	Non-curative endoscopic resection does not always lead to grave outcomes in submucosal invasive early gastric cancer.
Q48597860	Outcome of endoscopic submucosal dissection for gastric neoplasm in relationship to endoscopic classification of submucosal fibrosis
Q87691374	Risk factors and management of positive horizontal margin in early gastric cancer resected by en bloc endoscopic submucosal dissection
Q53055766	Risk factors for lymph node metastasis and long-term outcomes of patients with early gastric cancer after non-curative endoscopic submucosal dissection.
Q24602875	Treatment of gastric cancer
Q36081013	Useful condition of chromoendoscopy with indigo carmine and acetic acid for identifying a demarcation line prior to endoscopic submucosal dissection for early gastric cancer
Q40597694	Vonoprazan prevents bleeding from endoscopic submucosal dissection-induced gastric ulcers